Boris Dasen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Boris Dasen has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Mazzoleni
Department of Biomedical Engineering University of Basel Basel Switzerland
2 shared publications - Arnaud Scherberich
Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Basel, 4031 Basel, Switzerland
2 shared publications - Clémentine Le Magnen
Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland
2 shared publications - Ivan Martin
Department of Biomedical Engineering University of Basel Basel Switzerland
2 shared publications - Manuele Giuseppe Muraro
Tissue Engineering Department of Biomedicine University of Basel and University Hospital of Basel Basel Switzerland
2 shared publications - Robin Dolgos
Department of Biomedicine University of Basel and University Hospital of Basel Basel Switzerland
2 shared publications
Latest Publications
- Open Access
- 11 June 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (26) , e05893
A Fully Human Engineered Bone Niche With Endogenous Osteoclastogenesis Reveals Osteoclast‐Dependent Osteomimicry in Prostate Cancer Cells
Bone is the predominant site of metastasis in advanced prostate cancer (PCa), yet the mechanisms governing tumor‐bone interactions remain incompletely understood, thanks in part to the scarcity of relevant models. The role played by osteoclasts in such interactions is especially obscure. A modular human three‐dimensional (3D) in vitro bone niche model was developedThe model integrates osteoblasts and osteoclasts within a mineralized scaffold, recreating an endosteal‐like microenvironment for co‐culture with PCa cell lines and patient‐derived organoids (PDOs). The engineered construct maintains osteoblastic differentiation and supports osteoclastogenesis, confirmed by lineage markers including osteocalcin, osteopontin (OPN), and tartrate‐resistant acid phosphatase (TRAP). Co‐culture with PCa cells downregulates osteoblast‐ and osteoclast‐associated genes (IBSP, OPN, TRAP) in bone cells, suggesting tumor‐mediated suppression of bone remodeling. Conversely, co‐cultured PCa cells exhibit niche‐dependent osteomimicry, characterized by upregulation of osteoblastic (SPARC, BGLAP) and osteoclastic (TRAP) markers and strongly regulated by the presence of osteoclasts. The platform also supports engraftment and proliferation of PDOs without exogenous PCa‐specific growth factors, underscoring its translational relevance. This osteoblastic‐osteoclastic niche model provides a human system that captures PCa‐bone cell interactions in a clinically relevant context, with potential utility for mechanistic and translational studies.
- 11 June 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (26) , e05893
Open AccessA Fully Human Engineered Bone Niche With Endogenous Osteoclastogenesis Reveals Osteoclast‐Dependent Osteomimicry in Prostate Cancer Cells
Bone is the predominant site of metastasis in advanced prostate cancer (PCa), yet the mechanisms governing tumor‐bone interactions remain incompletely understood, thanks in part to the scarcity of relevant models. The role played by osteoclasts in such interactions is especially obscure. A modular human three‐dimensional (3D) in vitro bone niche model was developedThe model integrates osteoblasts and osteoclasts within a mineralized scaffold, recreating an endosteal‐like microenvironment for co‐culture with PCa cell lines and patient‐derived organoids (PDOs). The engineered construct maintains osteoblastic differentiation and supports osteoclastogenesis, confirmed by lineage markers including osteocalcin, osteopontin (OPN), and tartrate‐resistant acid phosphatase (TRAP). Co‐culture with PCa cells downregulates osteoblast‐ and osteoclast‐associated genes (IBSP, OPN, TRAP) in bone cells, suggesting tumor‐mediated suppression of bone remodeling. Conversely, co‐cultured PCa cells exhibit niche‐dependent osteomimicry, characterized by upregulation of osteoblastic (SPARC, BGLAP) and osteoclastic (TRAP) markers and strongly regulated by the presence of osteoclasts. The platform also supports engraftment and proliferation of PDOs without exogenous PCa‐specific growth factors, underscoring its translational relevance. This osteoblastic‐osteoclastic niche model provides a human system that captures PCa‐bone cell interactions in a clinically relevant context, with potential utility for mechanistic and translational studies.
- Open Access
Dual-Lineage Human 3D Bone Niche Model Reveals Osteoclast-Driven Osteomimicry in Prostate Cancer
Bone is the predominant site of metastasis in advanced prostate cancer (PCa), yet the mechanisms governing tumor-bone interactions remain incompletely understood. A modular human three-dimensional (3D) in vitro bone niche model is developed that integrates osteoblasts and osteoclasts within a mineralized scaffold, recreating an endosteal-like microenvironment for co-culture with PCa cell lines and patient-derived organoids (PDOs). The engineered construct maintains osteoblastic differentiation and supports osteoclastogenesis, confirmed by lineage markers including osteocalcin, osteopontin (OPN), and tartrate-resistant acid phosphatase (TRAP). Co-culture with PCa cells downregulates osteoblast- and osteoclast-associated genes (IBSP, OPN, TRAP) in bone cells, suggesting tumor-mediated suppression of bone remodeling. Conversely, co-cultured PCa cells exhibit niche-dependent osteomimicry, characterized by upregulation of osteoblastic (SPARC, BGLAP) and osteoclastic (TRAP) markers and strongly regulated by the presence of osteoclasts. The platform also supports engraftment and proliferation of PDOs without PCa-specific exogenous growth factors, underscoring its translational relevance. This osteoblastic-osteoclastic niche model thus provides a human system capturing PCa-bone cell interactions, with potential utility to investigate therapeutic responses in a clinically relevant context. Table of Contents: A human 3D bone niche integrating osteoblasts and osteoclasts enables co-culture with prostate cancer cell lines and patient-derived organoids. The engineered niche (i) models reciprocal phenotypic regulation between bone and cancer cells, (ii) captures osteoclast-enhanced osteomimicry in tumor cells and (iii) establishes a biomimetic platform for mechanistic studies of metastatic prostate cancer cells in bone.
Open AccessDual-Lineage Human 3D Bone Niche Model Reveals Osteoclast-Driven Osteomimicry in Prostate Cancer
Bone is the predominant site of metastasis in advanced prostate cancer (PCa), yet the mechanisms governing tumor-bone interactions remain incompletely understood. A modular human three-dimensional (3D) in vitro bone niche model is developed that integrates osteoblasts and osteoclasts within a mineralized scaffold, recreating an endosteal-like microenvironment for co-culture with PCa cell lines and patient-derived organoids (PDOs). The engineered construct maintains osteoblastic differentiation and supports osteoclastogenesis, confirmed by lineage markers including osteocalcin, osteopontin (OPN), and tartrate-resistant acid phosphatase (TRAP). Co-culture with PCa cells downregulates osteoblast- and osteoclast-associated genes (IBSP, OPN, TRAP) in bone cells, suggesting tumor-mediated suppression of bone remodeling. Conversely, co-cultured PCa cells exhibit niche-dependent osteomimicry, characterized by upregulation of osteoblastic (SPARC, BGLAP) and osteoclastic (TRAP) markers and strongly regulated by the presence of osteoclasts. The platform also supports engraftment and proliferation of PDOs without PCa-specific exogenous growth factors, underscoring its translational relevance. This osteoblastic-osteoclastic niche model thus provides a human system capturing PCa-bone cell interactions, with potential utility to investigate therapeutic responses in a clinically relevant context. Table of Contents: A human 3D bone niche integrating osteoblasts and osteoclasts enables co-culture with prostate cancer cell lines and patient-derived organoids. The engineered niche (i) models reciprocal phenotypic regulation between bone and cancer cells, (ii) captures osteoclast-enhanced osteomimicry in tumor cells and (iii) establishes a biomimetic platform for mechanistic studies of metastatic prostate cancer cells in bone.